| Literature DB >> 25889817 |
Jenny John1,2, Kathrin Roediger3, Wieland Schroedl4, Nada Aldaher5, Ingrid Vervuert6.
Abstract
BACKGROUND: Almost all foals develop transient diarrhoea within the first weeks of life. Studies indicated different viral, bacterial, and parasitic causes, such as rotavirus, Clostridium perfringens, Escherichia coli, and Cryptosporidium are discussed. But little is known about the development of intestinal microflora in foals. The present study investigated whether the supplementation with Bacillus cereus var. toyoi would modify the developing intestinal microflora and consequently reduce diarrhoea in foals. From birth, the foals were randomly assigned to three treatment groups: placebo (10 mL isotonic NaCl, n = 8), low dosage (LD; 5 × 10(8) cfu B. cereus var. toyoi, n = 7) and high dosage (HD; 2 × 10(9) cfu B. cereus var. toyoi, n = 10). Treatment groups were supplemented orally once a day for 58 days. Faeces scoring and sampling were performed within the first 24 h after birth and on day 9, 16, 23, 30, 44, 58 of the foal's life and also on the first day of diarrhoea. Culture-plate methods were used to analyse the bacterial microflora.Entities:
Mesh:
Year: 2015 PMID: 25889817 PMCID: PMC4333172 DOI: 10.1186/s12917-015-0355-3
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Number of foals with diarrhoea, duration of diarrhoea (days) and faecal score in placebo ( = 8), low dosage ( = 7), and high dosage ( = 10) during period of oral supplementation with var. (days 1 to 58 of life), data expressed as numbers, median, 25 and 75% quartile
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
| 7/8 | 5/7 | 10/10 | >0.05 | |
|
| ||||
| 25% quartile | 2 | 2 | 2.8 | 0.7072 |
| Median | 2.5 | 10 | 3.5 | |
| 75% quartile | 5.3 | 11 | 4.8 | |
|
| ||||
| 25% quartile | 3 | 2 | 2 | 0.132 |
| Median | 3 | 3 | 3 | |
| 75% quartile | 3 | 6 | 5 | |
Lactobacilli in faeces (cfu/g) of the foals from days 1 to 58 of life in placebo, low dosage (LD), and high dosage (HD) groups and for all foals, data expressed as numbers, median, 25 and 75% quartile, time p = 0.002, treatment p = 0.522
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| ||
|
| 25% quartile | 2.8 × 104 | 2.7 × 106 | 3.2 × 106 | 2.1 × 106 | 2.9 × 105 | 5.0 × 105 | 4.3 × 105 | 4.1 × 104 |
| Median | 3.4 × 104 | 1.7 × 107 | 2.5 × 107 | 2.0 × 107 | 1.4 × 106 | 1.0 × 106 | 1.9 × 106 | 2.2 × 105 | |
| 75% quartile | 4.0 × 105 | 8.3 × 107 | 4.0 × 107 | 3.0 × 107 | 5.0 × 106 | 2.5 × 106 | 2.6 × 106 | 3.3 × 105 | |
|
| 25% quartile | 1.9 × 104 | n.d. | 8.2 × 106 | 3.6 × 106 | 2.5 × 105 | 2.8 × 105 | 3.4 × 105 | 2.7 × 105 |
| Median | 4.0 × 105 | n.d. | 4.5 × 107 | 5.5 × 106 | 5.4 × 105 | 3.9 × 105 | 4.0 × 105 | 6.0 × 105 | |
| 75% quartile | 2.0 × 106 | n.d. | 6.7 × 107 | 1.9 × 107 | 2.9 × 106 | 4.2 × 105 | 5.4 × 105 | 9.7 × 105 | |
|
| 25% quartile | 7.0 × 103 | 2.3 × 106 | 4.7 × 106 | 4.2 × 106 | 2.7 × 105 | 3.1 × 105 | 1.4 × 105 | 1.5 × 105 |
| Median | 2.5 × 104 | 3.7 × 106 | 2.1 × 107 | 1.5 × 107 | 1.6 × 106 | 2.7 × 106 | 4.3 × 105 | 4.9 × 105 | |
| 75% quartile | 2.3 × 106 | 3.8 × 107 | 4.6 × 107 | 4.6 × 107 | 1.3 × 107 | 7.1 × 106 | 7.3 × 105 | 4.4 × 106 | |
|
| 25% quartile | 1.6 × 104 | 2.3 × 106 | 3.5 × 106 | 3.2 × 106 | 1.9 × 105 | 2.5 × 105 | 2.7 × 105 | 1.9 × 105 |
| Median | 3.4 × 104 | 3.7 × 106 | 2.3 × 107 | 1.7 × 106 | 1.3 × 106 | 6.0 × 105 | 5.0 × 105 | 3.2 × 105 | |
| 75% quartile | 2.2 × 106 | 4.5 × 107 | 5.0 × 107 | 2.8 × 107 | 5.0 × 106 | 2.9 × 106 | 1.2 × 106 | 1.0 × 106 | |
n.d.: non-determinable, total: over all treatments.
Detection rate (> 10 cfu/g,%) of enterococci in faeces of the foals from days 1 to 58 of life in placebo, low dosage (LD), and high dosage (HD) groups and for all foals, data expressed in %, treatment p > 0.05
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| 66,7% | 100.0% | 85.7% | 50.0% | 50.0% | 25.0% | 25.0% | 12.5% |
|
| 57.1% | n.d. | 85.7% | 85.7% | 42.9% | 42.9% | 42.9% | 14.3% |
|
| 60.0% | 83.3% | 100.0% | 60.0% | 40.0% | 40.0% | 40.0% | 30.0% |
|
| 61.1% | 90.0% | 91.7% | 64.0% | 44.0% | 36.0% | 36.0% | 20.0% |
n.d.: non-determinable, total: over all treatments.
Detection rate (> 10 cfu/g,%) of enterobacteria in faeces of the from days 1 to 58 of life in placebo, low dosage (LD), and high dosage (HD) groups and for all foals, data expressed in %, treatment p > 0.05
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| 0% | 25.0% | 14.3% | 25.0% | 25.0% | 37.5% | 37.5% | 50.0% |
|
| 28.6% | n.d. | 42.9% | 42.9% | 42.9% | 57.1% | 28.6% | 57.1% |
|
| 20.0% | 16.7% | 60.0% | 40.0% | 40.0% | 30.0% | 40.0% | 20.0% |
|
| 16.7% | 20.0% | 36.0% | 36.0% | 40.0% | 40.0% | 36.0% | 40.0% |
n.d.: non-determinable, total: over all treatments.
Detection rate (> 10 cfu/g,%) of in faeces of the foals from days 1 to 58 of life in placebo, low dosage (LD), and high dosage (HD) groups and for all, foals, data expressed in %, treatment p > 0.05
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| 50.0% | 100% | 42.9% | 25.0% | 12.5% | 0% | 0% | 0% |
|
| 71.4% | n.d. | 71.4% | 71.4% | 28.6% | 14.3% | 14.3% | 28.6% |
|
| 60.0% | 66.7% | 90.0% | 60.0% | 10.0% | 0% | 0% | 0% |
|
| 61.1% | 80.0% | 70.8% | 52.0% | 16.0% | 4.0% | 4.0% | 8.0% |
n.d.: non-determinable, total: over all treatments.
Time schedule of the study
|
|
|
| |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Health status | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Body weight | X | X | X | X | X | X | X | X | X | X | |||||
| Faeces | X | X | X | X | X | X | X | ||||||||
| Blood | X | X | X | X | X | ||||||||||
*Additional measurements and sampling were done on the first day of diarrhoea.
Faeces score
|
|
|
|---|---|
| 0 | Orange-brownish first faeces after meconium |
| 1 | Dry balled |
| 2 | Soft balled, formed |
| 3 | Not formed, soft |
| 4 | Pasty |
| 5 | Mushy |
| 6 | Inhomogeneous: structured and watery part |
| 7 | Mucous like |
| 8 | Green diarrhoea |
| 9 | Yellow diarrhoea |